Penlac® (Ciclopirox) - A - Detailing from Skin Therapy Letter

 

Penlac® (Ciclopirox)

 

 

  Content:

PATIENT SELECTION

 

 

In my experience, the patients most likely to have the best experience and be most successful with the use of Penlac are:

Monotherapy

1. patients with mild to moderate onychomycosis
  a. < 75% involvement with no lunular disease

2. patients who do not wish or are unable to take systemic medications

3. children wishing to avoid systemic medications

4. patients wishing to try to reduce their chance of relapse\reinfection following systemic therapy

Combination Therapy

1. patients who are interested in trying to reduce their systemic drug exposure

2. patients who wish to try and reduce their relapse\reinfection rate

3. patients with lateral nail disease or extensive onycholysis


Done.   Start Over.